SCYB Stock Overview
A technology company, provides platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Scryb Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.02 |
| 52 Week High | CA$0.09 |
| 52 Week Low | CA$0.015 |
| Beta | 0.064 |
| 11 Month Change | -20.00% |
| 3 Month Change | -33.33% |
| 1 Year Change | -76.47% |
| 33 Year Change | -91.11% |
| 5 Year Change | -91.67% |
| Change since IPO | -90.91% |
Recent News & Updates
Shareholder Returns
| SCYB | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | -3.3% | -2.3% |
| 1Y | -76.5% | -10.5% | 12.5% |
Return vs Industry: SCYB underperformed the Canadian Medical Equipment industry which returned -10.2% over the past year.
Return vs Market: SCYB underperformed the Canadian Market which returned 13.4% over the past year.
Price Volatility
| SCYB volatility | |
|---|---|
| SCYB Average Weekly Movement | 41.4% |
| Medical Equipment Industry Average Movement | 10.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.9% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: SCYB's share price has been volatile over the past 3 months.
Volatility Over Time: SCYB's weekly volatility has increased from 30% to 41% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Yoav Raiter | www.scryb.ai |
Scryb Inc., a technology company, provides platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The company offers Cybeats, a supply chain cybersecurity and IoT device security solution; Software Bill of Materials Studio, a solution designed to manage and distribute software bill of materials in a single platform; Fionet Platform, an end-to-end testing and tracking technology solution for community-based or decentralized settings; and Pharmatrac, a system that predicts medication behavior. It also provides nutraceutical and cannabinoid-based products.
Scryb Inc. Fundamentals Summary
| SCYB fundamental statistics | |
|---|---|
| Market cap | CA$5.82m |
| Earnings (TTM) | -CA$9.46m |
| Revenue (TTM) | CA$1.32m |
4.4x
P/S Ratio-0.6x
P/E RatioIs SCYB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SCYB income statement (TTM) | |
|---|---|
| Revenue | CA$1.32m |
| Cost of Revenue | CA$656.40k |
| Gross Profit | CA$662.08k |
| Other Expenses | CA$10.12m |
| Earnings | -CA$9.46m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 50.22% |
| Net Profit Margin | -717.18% |
| Debt/Equity Ratio | 1.8% |
How did SCYB perform over the long term?
See historical performance and comparison